Mark Berry

619 total citations
23 papers, 272 citations indexed

About

Mark Berry is a scholar working on Infectious Diseases, Neurology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Mark Berry has authored 23 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Neurology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Mark Berry's work include COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (11 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Mark Berry is often cited by papers focused on COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (11 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Mark Berry collaborates with scholars based in United States, United Kingdom and Germany. Mark Berry's co-authors include Y. Joseph Woo, Vivian Hsu, George P. Liao, William Hiesinger, Pavan Atluri, Kevin Morine, Ronald L. Hayes, Matthew A. Eisenberg, André C. Kalil and Aastha Chandak and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Mark Berry

20 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Berry United States	8	84	84	77	70	63	23	272
C. Lynch United Kingdom	10	21 0.3×	18 0.2×	125 1.6×	28 0.4×	17 0.3×	13	352
Jordan Westra United States	11	71 0.8×	11 0.1×	96 1.2×	30 0.4×	61 1.0×	42	400
Richard Summers South Africa	9	37 0.4×	100 1.2×	18 0.2×	20 0.3×	35 0.6×	29	323
Anders Holt Denmark	10	23 0.3×	42 0.5×	31 0.4×	81 1.2×	43 0.7×	41	385
Kristi Prather United States	9	62 0.7×	13 0.2×	28 0.4×	29 0.4×	141 2.2×	14	365
Taeyoung Choi United States	7	29 0.3×	322 3.8×	28 0.4×	307 4.4×	65 1.0×	12	611
Pauline Barbeau Canada	5	13 0.2×	78 0.9×	76 1.0×	31 0.4×	45 0.7×	6	244
Megan Van Berkel Patel United States	9	9 0.1×	31 0.4×	48 0.6×	38 0.5×	59 0.9×	30	309
G. Kernbach-Wighton Germany	11	33 0.4×	13 0.2×	30 0.4×	13 0.2×	24 0.4×	31	250
Amanda Arroyo United States	11	76 0.9×	6 0.1×	74 1.0×	15 0.2×	22 0.3×	35	522

Countries citing papers authored by Mark Berry

Since Specialization

Citations

This map shows the geographic impact of Mark Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Berry more than expected).

Fields of papers citing papers by Mark Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Berry. The network helps show where Mark Berry may publish in the future.

Co-authorship network of co-authors of Mark Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Berry. A scholar is included among the top collaborators of Mark Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Berry. Mark Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Seung-Won, Mark Berry, Jason M. Link, et al.. (2025). Protocol to purify and culture human pancreatic cancer cells from patient-derived xenografts. STAR Protocols. 6(1). 103672–103672.

Berry, Mark, Amanda M. Kong, Roger Paredes, et al.. (2025). Risk of Long COVID in hospitalized individuals treated with remdesivir for acute COVID-19. Scientific Reports. 15(1). 27441–27441. 1 indexed citations

Lee, Seung-Won, Mark Berry, Jinho Lee, et al.. (2025). HMG Box-containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic Progression. Cellular and Molecular Gastroenterology and Hepatology. 19(9). 101536–101536.

Iqbal, Shahed, Jeffrey J. Wallin, Wildaliz Nieves, et al.. (2025). Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank. Nature Communications. 16(1). 7009–7009.

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2024). Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era. Clinical Infectious Diseases. 79(Supplement_4). S149–S159. 3 indexed citations

Mozaffari, Essy, Aastha Chandak, André C. Kalil, et al.. (2024). Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen. Open Forum Infectious Diseases. 11(6). ofae202–ofae202. 6 indexed citations

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2024). Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores. Clinical Infectious Diseases. 79(Supplement_4). S167–S177. 1 indexed citations

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2024). Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study. Journal of Comparative Effectiveness Research. 13(4). e230131–e230131. 2 indexed citations

Mozaffari, Essy, Aastha Chandak, Mark Berry, et al.. (2024). Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals. Clinical Infectious Diseases. 79(Supplement_4). S137–S148. 4 indexed citations

10.

Mozaffari, Essy, Aastha Chandak, Andrew Ustianowski, et al.. (2024). Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients. Clinical Therapeutics. 46(10). 778–784. 1 indexed citations

11.

Mozaffari, Essy, Aastha Chandak, Alpesh Amin, et al.. (2024). Racial and Ethnic Disparities in COVID-19 Treatments in the United States. Journal of Racial and Ethnic Health Disparities. 12(2). 1052–1062. 1 indexed citations

12.

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2024). Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. Clinical Infectious Diseases. 80(1). 63–71. 5 indexed citations

13.

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2023). Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants. Open Forum Infectious Diseases. 10(10). ofad482–ofad482. 19 indexed citations

14.

Mozaffari, Essy, Aastha Chandak, Robert Gottlieb, et al.. (2023). Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice. Clinical Infectious Diseases. 77(12). 1626–1634. 34 indexed citations

15.

Kelly, J. Daniel, Mark Berry, Linda Chen, et al.. (2023). SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis. European Respiratory Review. 32(169). 220254–220254. 16 indexed citations

16.

Lankshear, Sara, Dimitrios X. G. Divaris, Mark Berry, et al.. (2015). Physician level reporting of surgical and pathology performance indicators: a regional study to assess feasibility and impact on quality. Canadian Journal of Surgery. 58(1). 31–40. 14 indexed citations

17.

Mannix, Rebekah, Matthew A. Eisenberg, Mark Berry, William P. Meehan, & Ronald L. Hayes. (2014). Serum Biomarkers Predict Acute Symptom Burden in Children after Concussion: A Preliminary Study. Journal of Neurotrauma. 31(11). 1072–1075. 35 indexed citations

18.

Atluri, Pavan, Kevin Morine, George P. Liao, et al.. (2006). Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cellular & Molecular Biology Letters. 12(1). 127–38. 88 indexed citations

19.

Wetta‐Hall, Ruth, et al.. (2004). Community Case Management: A Strategy to Improve Access to Medical Care in Uninsured Populations. Care management journals. 5(2). 87–93. 8 indexed citations

20.

Berry, Mark, et al.. (1996). Certification for child protective services staff members: the Texas initiative.. PubMed. 75(6). 727–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact